Skip to content
WeighLab
Menu
Ranked #185 · Grade C

NexLife review

NexLife is a LegitScript-certified compounded-GLP-1 and longevity telehealth platform under medical director Adam Kennah, M.D..

Visit NexLife Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$165/mo (all doses, compounded)
Tirzepatide
$215/mo (all doses, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Semaglutide · modeled / year

$1,980

Tirzepatide · modeled / year

$2,580

Pricing verified August 2026

The Index scorecard

NexLife scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month65/100
Price Transparency94/100
Nationwide Access24/100
Formulation Options66/100
Clinical Oversight76/100
Contract Flexibility47/100

Where the value is

  • Flat pricing confirmed at every dose for both drugs — no per-mg escalation during titration, unlike most compounded competitors in this batch
  • LegitScript certified with a named medical director (Adam Kennah, M.D.)
  • States every batch undergoes independent third-party testing for potency, sterility, pH, and endotoxin levels
  • Genuinely cancel-anytime, with FSA/HSA and Klarna/Affirm financing accepted

The tradeoffs

  • The commonly advertised '$186/mo' tirzepatide headline requires a 12-month commitment; the true no-commitment month-to-month price is $215/mo — about 16% more
  • No individual compounding pharmacy is named, only 'LegitScript-certified, NABP-accredited' pharmacies generically
  • No Certificate of Analysis (COA) is linked despite the batch-testing claim
  • The '$377 value' of bundled extras (nutrition plan, coaching call) is the company's own estimate, not an independently verifiable price
  • FDA issued Nexlife Inc. dba Nexlife a warning letter in June 2026; the letter is public in FDA's warning-letter database

The bottom line

Best for: Cost-first shoppers who want wanting a genuinely flat, dose-independent price and willing to prepay a multi-month term for the lowest advertised rate. NexLife is a LegitScript-certified compounded-GLP-1 and longevity telehealth platform under medical director Adam Kennah, M.D..

Ranked #185 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to NexLife.

The 24 programs nearest this one

Pricing, states and verification reflect NexLife's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on NexLife's site. Not medical advice; see our disclosure.

← Back to the value leaderboard